Eltrombopag is a small-molecule agonist of the c-mpl (TpoR) receptor, developed as a pharmaceutical active ingredient for conditions involving abnormally low platelet counts. It is a hydrazine derivative featuring a biphenyl carboxylic acid and a pyrazolone moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 496775-61-2
Eltrombopag olamine
pharmaceutical raw material
Eltrombopag Amide
pharmaceutical raw material
Eltrombopag Methyl Ester
pharmaceutical raw material
Methoxy Eltrombopag
pharmaceutical raw material
Algestone acetonide
pharmaceutical raw material
DL-dobutamine hydrochloride
pharmaceutical raw material
Garamine
pharmaceutical raw material
1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
pharmaceutical raw material
3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid
SVOQIEJWJCQGDQ-UHFFFAOYSA-N
CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C